Loading...
Loading...
“Riverbed's announcement today sends a clear message to shareholders: We don't
care what you think. Almost four months ago, shareholders clearly and
convincingly voted for meaningful change at Riverbed by voting off the only
Board member up for re-election and voting against the company's compensation
plan. The larger message behind this vote was clear: It was a resounding
rejection of Riverbed's refusal to engage with interested buyers and its
decision to entrench by adopting a poison pill.
Going against every modern principle of shareholder engagement and good
corporate governance, Riverbed's Board has decided to ignore the wishes of
shareholders on every count. The Board didn't just ignore the larger message
to stop entrenching and engage. It even decided to keep the Board member that
was voted off, failed to articulate any meaningful changes to the compensation
plan, and chose to keep its poison pill. Above all, the Board continues to
ignore serious acquisition interest even after the company publicly admitted
that it will miss its “10% growth plan” by a wide margin.
Elliott has worked collaboratively with numerous boards throughout our 37-year
history, but we have never seen a board so completely ignore shareholders in
this blatant a fashion. We have tried to engage with this Board, and our cash
offer of $21 per share for Riverbed still stands. However, the Board's
decision today indicates that these directors are simply not interested in
working with shareholders constructively. As one of the company's largest
shareholders, we intend to remain fully engaged, and we will continue to work
toward a value-maximizing outcome.”
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in